Niagen Bioscience, Inc. (NAGE) vs ProQR Therapeutics N.V. (PRQR)
Niagen Bioscience, Inc. and ProQR Therapeutics N.V. are both Biotechnology companies. Niagen Bioscience, Inc. and ProQR Therapeutics N.V. are of similar size ($238.2M and $236.1M). ProQR Therapeutics N.V. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. ProQR Therapeutics N.V. grew revenue faster over the last twelve months: 19.7% against 11.0%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −228.7%) and the higher return on invested capital (42.0% vs 0.00%). Across the 17 metrics below, Niagen Bioscience, Inc. leads on 14 and ProQR Therapeutics N.V. on 3.
Valuation
Profitability
| Metric | NAGE | PRQR | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.24% | 100.00% | 65.16% |
| Operating margin | 8.21% | (233.33%) | 0.00% |
| Net margin | 12.39% | (228.71%) | 0.00% |
| Free cash flow margin | 8.89% | (267.36%) | 0.00% |
| Return on equity | 21.80% | (58.29%) | (57.72%) |
| Return on assets | 16.14% | (31.53%) | (49.22%) |
| Return on invested capital | 41.95% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack